![Daniel Rowland Cowell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Rowland Cowell
Vorstandsvorsitzender bei Medeor Old Ltd.
Aktive Positionen von Daniel Rowland Cowell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sentinel Oncology Ltd.
![]() Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Medeor Old Ltd.
![]() Medeor Old Ltd. Miscellaneous Commercial ServicesCommercial Services Medeor Old Ltd. provides business support services. The company is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
techspert.io Ltd.
![]() techspert.io Ltd. Packaged SoftwareTechnology Services techspert.io Ltd. develops and provides artificial intelligence solutions for marketing products. The firm offers techspert.io platform. The company was founded by David Holden-White and Graham Mills on November 16, 2015 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 15.07.2016 | - |
Karriereverlauf von Daniel Rowland Cowell
Ehemalige bekannte Positionen von Daniel Rowland Cowell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sigma Entity One Ltd.
![]() Sigma Entity One Ltd. Miscellaneous Commercial ServicesCommercial Services Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom. | Gründer | 16.07.2003 | - |
Hypoxium Ltd. | Gründer | - | - |
Oxford Diversity, Inc. | Corporate Officer/Principal | - | - |
Cambridge Material Science, Inc. | Corporate Officer/Principal | - | - |
Cambridge Combinatorial Ltd.
![]() Cambridge Combinatorial Ltd. Industrial ConglomeratesProducer Manufacturing Part of Dassault Systèmes SA, Cambridge Combinatorial Ltd. is a company engaged in the design, production and supply of compounds for the pharmaceutical industry. The company is based in Cambridge, UK. Cambridge Combinatorial was acquired by Oxford Molecular Group Plc on October 15, 1998 for $20.78 million. The British company was founded by Allan P. Marchington. | Corporate Officer/Principal | - | - |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Statistik
International
Vereinigtes Königreich | 8 |
Vereinigte Staaten | 4 |
Operativ
Corporate Officer/Principal | 5 |
Director/Board Member | 4 |
Founder | 2 |
Sektoral
Commercial Services | 5 |
Health Technology | 3 |
Producer Manufacturing | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 10 |
---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Cambridge Combinatorial Ltd.
![]() Cambridge Combinatorial Ltd. Industrial ConglomeratesProducer Manufacturing Part of Dassault Systèmes SA, Cambridge Combinatorial Ltd. is a company engaged in the design, production and supply of compounds for the pharmaceutical industry. The company is based in Cambridge, UK. Cambridge Combinatorial was acquired by Oxford Molecular Group Plc on October 15, 1998 for $20.78 million. The British company was founded by Allan P. Marchington. | Producer Manufacturing |
Sigma Entity One Ltd.
![]() Sigma Entity One Ltd. Miscellaneous Commercial ServicesCommercial Services Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom. | Commercial Services |
Sentinel Oncology Ltd.
![]() Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Medeor Old Ltd.
![]() Medeor Old Ltd. Miscellaneous Commercial ServicesCommercial Services Medeor Old Ltd. provides business support services. The company is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Hypoxium Ltd. | Commercial Services |
Cambridge Material Science, Inc. | |
Oxford Diversity, Inc. | |
techspert.io Ltd.
![]() techspert.io Ltd. Packaged SoftwareTechnology Services techspert.io Ltd. develops and provides artificial intelligence solutions for marketing products. The firm offers techspert.io platform. The company was founded by David Holden-White and Graham Mills on November 16, 2015 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
Horizon Discovery Ltd.
![]() Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Börse
- Insiders
- Daniel Rowland Cowell
- Erfahrung